peter attia on semaglutide A patient loses 22 pounds over 8 months. Her doctor orders a DXA scan. The report comes back: 38% of what she lost was lean mass. Both her doctor and GLP-1 drugs fail to slow

Shen J, et al

[1] The SURMOUNT clinical trial program, which evaluated tirzepatide for weight management in over 5,000 participants, did not report sexual dysfunction as a notable adverse event

& Cahill, K.N

Wegovy dosing Wegovy comes in five doses: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg

GLP-1 therapies may also help improve metabolic health and body composition, making them an effective option for individuals seeking long-term weight management support

As the most commonly approved nanomedicines by the US FDA, 128 lipid-based nanoparticles afford many advantages such as relatively simple formulation, self-assembled structure, biocompatibility, drug load capacity, and adjustable physicochemical properties to suit biological characteristics